Literature DB >> 16207856

Cost-effectiveness in a flat world--can ICDs help the United States get rhythm?

Lee Goldman.   

Abstract

Mesh：

Year:  2005        PMID： 16207856     DOI： 10.1056/NEJM2e058214

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Rebecca I Hartman; Mukesh G Harisinghani; Adam S Feldman; Peter R Mueller; G Scott Gazelle
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

2.  Visual screening for malignant melanoma: a cost-effectiveness analysis.

Authors:  Elena Losina; Rochelle P Walensky; Alan Geller; Frederick C Beddingfield; Lindsey L Wolf; Barbara A Gilchrest; Kenneth A Freedberg
Journal:  Arch Dermatol       Date:  2007-01

3.  Twenty years of cost-effectiveness analysis in medical imaging: are we improving?

Authors:  Hansel J Otero; Frank J Rybicki; Dan Greenberg; Peter J Neumann
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

Review 4.  Survival is not the only valuable end point in melanoma screening.

Authors:  Clara Curiel-Lewandrowski; Caroline C Kim; Susan M Swetter; Suephy C Chen; Allan C Halpern; John M Kirkwood; Sancy A Leachman; Ashfaq A Marghoob; Michael E Ming; James M Grichnik
Journal:  J Invest Dermatol       Date:  2012-02-16       Impact factor: 8.551

5.  Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Peter R Mueller; Chin Hur; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

6.  Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting.

Authors:  Patrick Langford; Paul Chrisp
Journal:  Core Evid       Date:  2010-10-21

7.  Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-09-01

8.  MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis.

Authors:  Chung Y Kong; Lesley Meng; Zehra B Omer; J Shannon Swan; Serene Srouji; G Scott Gazelle; Fiona M Fennessy
Journal:  AJR Am J Roentgenol       Date:  2014-08       Impact factor: 3.959

9.  Advance Care Planning Documentation and Intensity of Care at the End of Life for Adults With Congestive Heart Failure, Chronic Kidney Disease, and Both Illnesses.

Authors:  Gwen M Bernacki; Cara L McDermott; Daniel D Matlock; Ann M O'Hare; Lyndia Brumback; Nisha Bansal; James N Kirkpatrick; Ruth A Engelberg; Jared Randall Curtis
Journal:  J Pain Symptom Manage       Date:  2021-08-04       Impact factor: 3.612

10.  Long-term outcomes of heart failure patients who received primary prevention implantable cardioverter-defibrillator: An observational study.

Authors:  Khang-Li Looi; Karishma Sidhu; Lisa Cooper; Liane Dawson; Debbie Slipper; Andrew Gavin; Nigel Lever
Journal:  J Arrhythm       Date:  2017-12-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.